Developing highly sensitive point-of-care molecular diagnostic devices malaria eradication
|Professor Patrick Kwanfirstname.lastname@example.org||+61 3 9342 7722|
Detection of very low-density malaria infection is essential for malaria elimination, but current diagnostics are insensitive and/or costly. We are developing a low-cost, point-of-care diagnostic device based on our novel electrical immunosensor platform with ultra-sensitive detection capacity. The platform will be applicable to blood (for detection of very low density infection) and saliva (for non-invasive testing) to fulfill diagnostic gaps required for malaria elimination.
Prof Stephen Rogerson, Doherty Institute and Department of Medicine (RMH/WH), The University of Melbourne